Comment on: Monoclonal gammopathy of undetermined significance, smoldering multiple myeloma, and curcumin: a randomized, double-blind placebo-controlled crossover 4g study and an open-label 8g extension study.

Vermorken, Alphons JM;Zhu, Jingjing;Van de Ven, Wim JM;Andrès, Emmanuel
(2012) American Journal of Hematology — Vol. 87, n° 10, p. E80 (2012)

Files

No attached file found for this publication.

Details

Authors
  • Vermorken, Alphons JMKULeuven
    Author
  • Zhu, Jingjingorcid-logoKULeuven
    Author
  • Van de Ven, Wim JMKULeuven
    Author
  • Andrès, EmmanuelKULeuven
    Author
Abstract
Comment in: Response to Vermorken et al--curcumin and free light chains. [Am J Hematol. 2012] Comment on: Monoclonal gammopathy of undetermined significance, smoldering multiple myeloma, and curcumin: a randomized, double-blind placebo-controlled cross-over 4g study and an open-label 8g extension study. [Am J Hematol. 2012]
Affiliations
  • KULLaboratory of Molecular Oncology

Citations

  • APA
  • Chicago
  • FWB

Vermorken, A. J., Zhu, J., Van de Ven, W. J., & Andrès, E. (2012). Comment on: Monoclonal gammopathy of undetermined significance, smoldering multiple myeloma, and curcumin: a randomized, double-blind placebo-controlled crossover 4g study and an open-label 8g extension study. American Journal of Hematology, 87(10), E80. https://doi.org/10.1002/ajh.23276 (Original work published 2012)